Analysts Adjust Ratings and Price Targets for Dolby Laboratories

Recent activity among analysts has led to significant changes in the ratings and price targets for Dolby Laboratories (NYSE: DLB). On November 22, 2025, Wall Street Zen downgraded the company’s stock from a “buy” rating to a “hold” rating, indicating a more cautious outlook. Just a few days before, on November 19, analysts at Rosenblatt Securities reduced their price target from $95.00 to $85.00, while maintaining a “buy” rating. That same day, Barrington Research also lowered its price target, moving it from $100.00 to $95.00, but kept an “outperform” rating.

In an earlier update on November 13, Weiss Ratings reaffirmed its “hold (c-)” rating for Dolby Laboratories, reflecting consistent sentiment among analysts about the stock’s performance. This follows a similar reaffirmation of their “hold (c)” rating on October 8, 2025.

Dividend Announcement and Insider Transactions

In addition to the changes in analyst ratings, Dolby Laboratories announced an increase in its quarterly dividend. The company plans to pay $0.36 per share on December 10, 2025, with shareholders of record on December 2 set to receive this payment. This marks an increase from the previous quarterly dividend of $0.33, translating to an annualized dividend of $1.44 and a yield of 2.1%. The current payout ratio stands at 54.75%.

Recent insider trading activity has also drawn attention. On November 24, CEO Kevin J. Yeaman sold 36,699 shares of the company at an average price of $66.91, resulting in a transaction valued at approximately $2,455,530.09. Following this sale, Yeaman holds 114,725 shares, valued at around $7,676,249.75, reflecting a 24.24% decrease in his ownership position.

Similarly, Senior Vice President John D. Couling sold 6,164 shares on November 20, at an average price of $66.12, amounting to $407,563.68. After this transaction, Couling retains 115,338 shares valued at approximately $7,626,148.56, a decrease of 5.07% in his stake.

Over the past quarter, insiders have sold a total of 95,863 shares, valued at around $6,572,994. Currently, insiders own 38.39% of Dolby Laboratories’ stock.

Company Overview

Dolby Laboratories, Inc. specializes in audio and imaging technologies that enhance entertainment across various platforms, including cinemas, digital television transmissions, mobile devices, and home entertainment systems. The company develops and licenses innovative audio technologies such as AAC & HE-AAC, AVC, and Dolby Atmos, which are widely used in numerous media applications.

As analysts adjust their ratings and price targets, Dolby Laboratories continues to navigate the evolving landscape of audio technology, while maintaining a commitment to delivering high-quality audio experiences to consumers worldwide.